tetano
Editor, Senior Moderator
Clin Infect Dis. 2020 Apr 9. pii: ciaa407. doi: 10.1093/cid/ciaa407. [Epub ahead of print]
Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018.
Tenforde MW[SUP]1[/SUP], Chung J[SUP]1[/SUP], Smith ER[SUP]1,[/SUP][SUP]2[/SUP], Talbot HK[SUP]3[/SUP], Trabue CH[SUP]4[/SUP], Zimmerman RK[SUP]5[/SUP], Silveira FP[SUP]5[/SUP], Gaglani M[SUP]6[/SUP], Murthy K[SUP]6[/SUP], Monto AS[SUP]7[/SUP], Martin ET[SUP]7[/SUP], McLean HQ[SUP]8[/SUP], Belongia EA[SUP]8[/SUP], Jackson LA[SUP]9[/SUP], Jackson ML[SUP]9[/SUP], Ferdinands JM[SUP]1[/SUP], Flannery B[SUP]1[/SUP], Patel MM[SUP]1[/SUP].
Author information
Abstract
BACKGROUND:
Demonstration of influenza vaccine effectiveness (VE) against hospitalization for severe illness in addition to milder outpatient illness may strengthen vaccination messaging and improve suboptimal uptake in the U.S. Our objective was to compare patient characteristics and VE between U.S. inpatient and outpatient VE networks.
METHODS:
We tested adults ≥18-years with acute respiratory illness (ARI) for influenza within two VE networks, one outpatient- and the other hospital-based, from 2015-2018. We compared age, sex, and chronic high-risk conditions between populations. The test-negative design was used to compare vaccination odds in influenza-positive cases versus influenza-negative controls. We estimated VE using logistic regression adjusting for site, age, sex, race/ethnicity, peak influenza activity, time-to-testing from symptom-onset, season (overall VE) and underlying conditions. VE differences (ΔVE) were assessed with 95% confidence intervals (CI) determined through bootstrapping with significance defined as excluding the null.
RESULTS:
The VE networks enrolled 14,573 (4144 influenza-positive) outpatients and 6769 (1452 influenza-positive) inpatients. Inpatients were older (median 62-years vs. 49-years) and had more high-risk conditions (median 4 vs. 1). Overall influenza VE across seasons was 31% (95%CI:26%-37%) among outpatients and 36% (27%-44%) among inpatients. Strain-specific VE among outpatients versus inpatients was 37% (25%-47%) vs. 53% (37%-64%) against H1N1pdm09, 19% (9%-27%) vs. 23% (8%-35%) against H3N2, and 46% (38%-53%) vs. 46% (31%-58%) against B-viruses. ΔVE was not significant for any comparison across all sites.
CONCLUSIONS:
Inpatients and outpatients with ARI represent distinct populations. Despite comparatively poor health status among inpatients, influenza vaccination was effective in preventing hospitalizations associated with influenza.
Published by Oxford University Press for the Infectious Diseases Society of America 2020. This work is written by (a) US Government employee(s) and is in the public domain in the US.
KEYWORDS:
attenuation; hospitalization; influenza; severity; vaccine effectiveness
PMID:32270198DOI:10.1093/cid/ciaa407
Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018.
Tenforde MW[SUP]1[/SUP], Chung J[SUP]1[/SUP], Smith ER[SUP]1,[/SUP][SUP]2[/SUP], Talbot HK[SUP]3[/SUP], Trabue CH[SUP]4[/SUP], Zimmerman RK[SUP]5[/SUP], Silveira FP[SUP]5[/SUP], Gaglani M[SUP]6[/SUP], Murthy K[SUP]6[/SUP], Monto AS[SUP]7[/SUP], Martin ET[SUP]7[/SUP], McLean HQ[SUP]8[/SUP], Belongia EA[SUP]8[/SUP], Jackson LA[SUP]9[/SUP], Jackson ML[SUP]9[/SUP], Ferdinands JM[SUP]1[/SUP], Flannery B[SUP]1[/SUP], Patel MM[SUP]1[/SUP].
Author information
Abstract
BACKGROUND:
Demonstration of influenza vaccine effectiveness (VE) against hospitalization for severe illness in addition to milder outpatient illness may strengthen vaccination messaging and improve suboptimal uptake in the U.S. Our objective was to compare patient characteristics and VE between U.S. inpatient and outpatient VE networks.
METHODS:
We tested adults ≥18-years with acute respiratory illness (ARI) for influenza within two VE networks, one outpatient- and the other hospital-based, from 2015-2018. We compared age, sex, and chronic high-risk conditions between populations. The test-negative design was used to compare vaccination odds in influenza-positive cases versus influenza-negative controls. We estimated VE using logistic regression adjusting for site, age, sex, race/ethnicity, peak influenza activity, time-to-testing from symptom-onset, season (overall VE) and underlying conditions. VE differences (ΔVE) were assessed with 95% confidence intervals (CI) determined through bootstrapping with significance defined as excluding the null.
RESULTS:
The VE networks enrolled 14,573 (4144 influenza-positive) outpatients and 6769 (1452 influenza-positive) inpatients. Inpatients were older (median 62-years vs. 49-years) and had more high-risk conditions (median 4 vs. 1). Overall influenza VE across seasons was 31% (95%CI:26%-37%) among outpatients and 36% (27%-44%) among inpatients. Strain-specific VE among outpatients versus inpatients was 37% (25%-47%) vs. 53% (37%-64%) against H1N1pdm09, 19% (9%-27%) vs. 23% (8%-35%) against H3N2, and 46% (38%-53%) vs. 46% (31%-58%) against B-viruses. ΔVE was not significant for any comparison across all sites.
CONCLUSIONS:
Inpatients and outpatients with ARI represent distinct populations. Despite comparatively poor health status among inpatients, influenza vaccination was effective in preventing hospitalizations associated with influenza.
Published by Oxford University Press for the Infectious Diseases Society of America 2020. This work is written by (a) US Government employee(s) and is in the public domain in the US.
KEYWORDS:
attenuation; hospitalization; influenza; severity; vaccine effectiveness
PMID:32270198DOI:10.1093/cid/ciaa407